MSAI Q1 2026 Earnings EPS Surprise Beats Estimates Stock Rises Amid Revenue Uncertainty Target Q1 2026 Earnings EPS of 171 Amid Mixed Consumer Environment Cartesian Therapeutics RNAC Q1 2026 Earnings WiderThanAnticipated Loss Masks Progress in CART Pipeline ADUS Q1 2026 Earnings EPS Surpasses Estimates Amid Tight Labor Market Encompass Health Q1 2026 Earnings EPS Surpasses Estimates by 58 Amid Mixed Market Reaction BA Q1 2026 Earnings Loss Narrows as EPS Surprises to the Upside